Diagnostic Errors in Clinical Microbiology and Antimicrobial Resistance
06 December 2019
Antimicrobial resistance (AMR) is a serious public health threat worldwide, and is leading to resurgence of untreatable infectious diseases. However, AMR surveillance in low and middle-income countries (LMICs) may not be of appropriate level. Optimum utilisation of clinical microbiology services requires an integrated effort of several hospital services including supportive management and dedicated nursing staff. It requires regular and persistent motivation at all levels of the healthcare.
Further reading: Current Medicine Research and Practice
Author(s): Tulsi Chugh
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
